Guidance Before Reading
Critical Axes and Publication Limitations
- Article Type: Intervention. The topic is organized across three decision axes, not by a general yes/no judgment.
- Evidence Basis: Grade B evidence, moderate conclusion strength, 9 evaluated studies (2 strong / 7 with reservations). Two Cochrane or NMA works support the core findings.
- Bias Risk: low to moderate. CoI Risk: low. Source Integrity: clean, no retractions.
- Main Limitation: Study populations are young and have extrinsic staining. Intrinsic cases are missing.
Clinical Question
How effective is whitening clinically, what side effects are documented based on evidence, and where are the real limits of applicability to daily clinical practice?
Executive Summary
The local body of literature supports the fundamental lightening effect of peroxide-based whitening agents. The signal is consistent across application systems (tray gels, strips, paint-on) and is supported by a Cochrane review and two network meta-analyses. [1, 2, 3]
The decisive variable is not the application system itself, but the combination of active ingredient concentration and cumulative contact time. OTC products under 3% hydrogen peroxide do not exceed the limit of detection compared to placebo in the NMA. [2]
The conclusion does not rely on a general overall judgment, but rather follows three clinical decision axes: whitening efficacy, concentration-dependent side effects, and limits of study applicability.
How DDJ Approaches This Topic
DDJ treats whitening as an intervention article. This means that the text is not guided by an abstract benefit-risk balance, but by concrete decision axes where the evidence varies.
The body of literature is predominantly shaped by reviews and meta-analyses. This provides a stronger assessment of the overall situation than individual studies, but limits granularity for specific clinical sub-questions. The two strong sources—the Cochrane review from 2018 [1] and the NMA from de Oliveira 2024 [2]—form the backbone. The NMA on tooth sensitivity by Terra 2025 [3] provides the strongest risk signal.
Claim Clusters and Decision Axes
Claim Cluster 1
Efficacy of Lightening
Clinical Axis: How robust is the evidence that peroxide-based whitening causes clinically measurable whitening?
Why this axis matters: The fundamental efficacy signal across different application systems is prerequisite for any product recommendation or treatment decision.
Evidence Status (C01): Peroxide-based whitening agents achieve statistically demonstrable tooth whitening compared to placebo over time periods ranging from two weeks to six months. The effect is consistent across tray gels, strips, and paint-on systems, with its magnitude depending on the active ingredient concentration and cumulative contact time. [1, 2]
Concentration Threshold (C02): OTC products with less than 3% hydrogen peroxide do not exceed the limit of detection compared to placebo in the NMA. A clinically noticeable whitening effect requires higher concentrations and sufficient cumulative contact time. [2, 1]
Standard Protocol (C03): Professionally supervised tray protocols using 10% carbamide peroxide over at least two weeks are the best-documented at-home standard protocol. OTC strips with 6% hydrogen peroxide show no significant inferiority in instrumental color measurement, but tend to perform worse in clinical shade guide evaluation. This discrepancy between instrumental and clinical measurement is methodologically significant and should be communicated during consultation. [2, 1]
Where the signal is stable: Consistent whitening effect at concentrations above the placebo level, across multiple application systems.
Where uncertainty begins: In the low-concentration OTC range below 3% HP, the efficacy signal is missing. The discrepancy between instrumental and clinical color measurement remains methodologically open.
Clinical Implication: The concentration-contact time relationship guides product recommendation more strongly than the application system. Low-concentration OTC products below 3% HP are not an evidence-based whitening protocol according to current NMA data.
Claim Cluster 2
Sensitivity and Side Effects
Clinical Axis: Which side effects are concentration-dependent, and how severe are they clinically?
Why this axis matters: Tooth sensitivity is the most common reason for treatment discontinuation during whitening. The concentration dependence of the risk of sensitivity has direct consequences for product selection in at-risk patients.